tirzepatide not available In adults with obesity but diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Tirzepatide not linked to increased

The recommended diluent is 0.9% Sodium Chloride injection (0.9% NaCl)

Tirzepatide has shown superior glycemic control, reducing fasting glucose by 15 to 20 mg/dL and HbA1C by 1% more than semaglutide and insulin Glargine (8082)

Waist circumference and other body measurements can be tracked

Getting the brand name right on the prescription matters

Introduction Evidence from trials and real-world studies in patients with type 2 diabetes (T2D) indicates that the risk of complications may be reduced by providing sustained glycemic control and that near-normal glycated hemoglobin (HbA 1c ) levels should be achieved as early as possible in the T2D trajectory (1, 2)